Atorvastatin Improves Myocardial Perfusion in a Patient With Hypercholesterolemia and Single-Vessel Coronary Disease

Lipid-lowering agents may improve the prognosis in patients with coronary artery disease (CAD) or with risk factors for atherosclerosis. A high dose of atorvastatin (80 mg/d) reduced the LDL cholesterol level in stable patients with CAD and was seen to be as effective as coronary angioplasty in redu...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clinical nuclear medicine 2006-03, Vol.31 (3), p.166-167
Hauptverfasser: Feola, Mauro, Biggi, Alberto, Rolfo, Fabrizio, Papaleo, Alberto, Chauvie, Stephane, Scala, Eugenio La, Uslenghi, Eugenio
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 167
container_issue 3
container_start_page 166
container_title Clinical nuclear medicine
container_volume 31
creator Feola, Mauro
Biggi, Alberto
Rolfo, Fabrizio
Papaleo, Alberto
Chauvie, Stephane
Scala, Eugenio La
Uslenghi, Eugenio
description Lipid-lowering agents may improve the prognosis in patients with coronary artery disease (CAD) or with risk factors for atherosclerosis. A high dose of atorvastatin (80 mg/d) reduced the LDL cholesterol level in stable patients with CAD and was seen to be as effective as coronary angioplasty in reducing the incidence of ischemic events. In patients with acute coronary syndrome, high-dose atorvastatin (80 mg/d) has lowered the incidence of recurrent ischemic events and emergency rehospitalization. We demonstrated that long-term oral low-dose (10 mg/d) administration of atorvastatin improved myocardial uptake of Tc-99m tetrofosmin in a patient with single-vessel coronary artery disease normalizing the plasma level of LDL cholesterol. The normalization of the perfusion pattern was obtained using the same protocol and level of physical stress after 10 months of therapy.
doi_str_mv 10.1097/01.rlu.0000200731.36549.d7
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_67689224</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>67689224</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3054-cd79fff75422e3943112e8b9c1eadadd8cf5b13fda332c9d774eb7a0e96463fa3</originalsourceid><addsrcrecordid>eNpFkF1vFCEUhonR2LX6FwzxwrsZ-RpYvGvWjzapsYlfl4SFg4sywxZm2uy_F7ublAQOF895OTwIvaGkp0Srd4T2JS09aYsRojjtuRyE7r16glZ04LIjjOmnaEW45J1Wkp2hF7X-IYRKKsVzdNZOPShBV2i-mHO5s3W2c5zw1bgv-Q4q_nLIzhYfbcI3UMJSY55wAyy-aSBMM_4V5x2-POyhuF1OUGcorYzRYjt5_C1OvxN0P6FWSHiTS55sOeAPsYKt8BI9CzZVeHWq5-jHp4_fN5fd9dfPV5uL685xMojOeaVDCGoQjAHXglPKYL3VjoL11vu1C8OW8uAt58xpr5SArbIEtBSSB8vP0dtjbvvV7dJmNGOsDlKyE-SlGqnkWjMmGvj-CLqSay0QzL7EsU1sKDH_nRtCTXNuHp2bB-fGq9b8-vTKsh3BP7aeJDdAHIH7nJqm-jct91DMDmyadw-RnCjWtVzZboR0bVPB_wEMh5Ef</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>67689224</pqid></control><display><type>article</type><title>Atorvastatin Improves Myocardial Perfusion in a Patient With Hypercholesterolemia and Single-Vessel Coronary Disease</title><source>MEDLINE</source><source>Journals@Ovid Complete</source><creator>Feola, Mauro ; Biggi, Alberto ; Rolfo, Fabrizio ; Papaleo, Alberto ; Chauvie, Stephane ; Scala, Eugenio La ; Uslenghi, Eugenio</creator><creatorcontrib>Feola, Mauro ; Biggi, Alberto ; Rolfo, Fabrizio ; Papaleo, Alberto ; Chauvie, Stephane ; Scala, Eugenio La ; Uslenghi, Eugenio</creatorcontrib><description>Lipid-lowering agents may improve the prognosis in patients with coronary artery disease (CAD) or with risk factors for atherosclerosis. A high dose of atorvastatin (80 mg/d) reduced the LDL cholesterol level in stable patients with CAD and was seen to be as effective as coronary angioplasty in reducing the incidence of ischemic events. In patients with acute coronary syndrome, high-dose atorvastatin (80 mg/d) has lowered the incidence of recurrent ischemic events and emergency rehospitalization. We demonstrated that long-term oral low-dose (10 mg/d) administration of atorvastatin improved myocardial uptake of Tc-99m tetrofosmin in a patient with single-vessel coronary artery disease normalizing the plasma level of LDL cholesterol. The normalization of the perfusion pattern was obtained using the same protocol and level of physical stress after 10 months of therapy.</description><identifier>ISSN: 0363-9762</identifier><identifier>EISSN: 1536-0229</identifier><identifier>DOI: 10.1097/01.rlu.0000200731.36549.d7</identifier><identifier>PMID: 16495741</identifier><language>eng</language><publisher>United States: Lippincott Williams &amp; Wilkins, Inc</publisher><subject>Anticholesteremic Agents - administration &amp; dosage ; Atorvastatin Calcium ; Coronary Artery Disease - complications ; Coronary Artery Disease - drug therapy ; Coronary Circulation - drug effects ; Heptanoic Acids ; Humans ; Hypercholesterolemia - complications ; Hypercholesterolemia - diagnostic imaging ; Hypercholesterolemia - drug therapy ; Male ; Middle Aged ; Organophosphorus Compounds ; Organotechnetium Compounds ; Pyrroles ; Radionuclide Imaging ; Radiopharmaceuticals ; Treatment Outcome</subject><ispartof>Clinical nuclear medicine, 2006-03, Vol.31 (3), p.166-167</ispartof><rights>2006 Lippincott Williams &amp; Wilkins, Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c3054-cd79fff75422e3943112e8b9c1eadadd8cf5b13fda332c9d774eb7a0e96463fa3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,778,782,27907,27908</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16495741$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Feola, Mauro</creatorcontrib><creatorcontrib>Biggi, Alberto</creatorcontrib><creatorcontrib>Rolfo, Fabrizio</creatorcontrib><creatorcontrib>Papaleo, Alberto</creatorcontrib><creatorcontrib>Chauvie, Stephane</creatorcontrib><creatorcontrib>Scala, Eugenio La</creatorcontrib><creatorcontrib>Uslenghi, Eugenio</creatorcontrib><title>Atorvastatin Improves Myocardial Perfusion in a Patient With Hypercholesterolemia and Single-Vessel Coronary Disease</title><title>Clinical nuclear medicine</title><addtitle>Clin Nucl Med</addtitle><description>Lipid-lowering agents may improve the prognosis in patients with coronary artery disease (CAD) or with risk factors for atherosclerosis. A high dose of atorvastatin (80 mg/d) reduced the LDL cholesterol level in stable patients with CAD and was seen to be as effective as coronary angioplasty in reducing the incidence of ischemic events. In patients with acute coronary syndrome, high-dose atorvastatin (80 mg/d) has lowered the incidence of recurrent ischemic events and emergency rehospitalization. We demonstrated that long-term oral low-dose (10 mg/d) administration of atorvastatin improved myocardial uptake of Tc-99m tetrofosmin in a patient with single-vessel coronary artery disease normalizing the plasma level of LDL cholesterol. The normalization of the perfusion pattern was obtained using the same protocol and level of physical stress after 10 months of therapy.</description><subject>Anticholesteremic Agents - administration &amp; dosage</subject><subject>Atorvastatin Calcium</subject><subject>Coronary Artery Disease - complications</subject><subject>Coronary Artery Disease - drug therapy</subject><subject>Coronary Circulation - drug effects</subject><subject>Heptanoic Acids</subject><subject>Humans</subject><subject>Hypercholesterolemia - complications</subject><subject>Hypercholesterolemia - diagnostic imaging</subject><subject>Hypercholesterolemia - drug therapy</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Organophosphorus Compounds</subject><subject>Organotechnetium Compounds</subject><subject>Pyrroles</subject><subject>Radionuclide Imaging</subject><subject>Radiopharmaceuticals</subject><subject>Treatment Outcome</subject><issn>0363-9762</issn><issn>1536-0229</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpFkF1vFCEUhonR2LX6FwzxwrsZ-RpYvGvWjzapsYlfl4SFg4sywxZm2uy_F7ublAQOF895OTwIvaGkp0Srd4T2JS09aYsRojjtuRyE7r16glZ04LIjjOmnaEW45J1Wkp2hF7X-IYRKKsVzdNZOPShBV2i-mHO5s3W2c5zw1bgv-Q4q_nLIzhYfbcI3UMJSY55wAyy-aSBMM_4V5x2-POyhuF1OUGcorYzRYjt5_C1OvxN0P6FWSHiTS55sOeAPsYKt8BI9CzZVeHWq5-jHp4_fN5fd9dfPV5uL685xMojOeaVDCGoQjAHXglPKYL3VjoL11vu1C8OW8uAt58xpr5SArbIEtBSSB8vP0dtjbvvV7dJmNGOsDlKyE-SlGqnkWjMmGvj-CLqSay0QzL7EsU1sKDH_nRtCTXNuHp2bB-fGq9b8-vTKsh3BP7aeJDdAHIH7nJqm-jct91DMDmyadw-RnCjWtVzZboR0bVPB_wEMh5Ef</recordid><startdate>200603</startdate><enddate>200603</enddate><creator>Feola, Mauro</creator><creator>Biggi, Alberto</creator><creator>Rolfo, Fabrizio</creator><creator>Papaleo, Alberto</creator><creator>Chauvie, Stephane</creator><creator>Scala, Eugenio La</creator><creator>Uslenghi, Eugenio</creator><general>Lippincott Williams &amp; Wilkins, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>200603</creationdate><title>Atorvastatin Improves Myocardial Perfusion in a Patient With Hypercholesterolemia and Single-Vessel Coronary Disease</title><author>Feola, Mauro ; Biggi, Alberto ; Rolfo, Fabrizio ; Papaleo, Alberto ; Chauvie, Stephane ; Scala, Eugenio La ; Uslenghi, Eugenio</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3054-cd79fff75422e3943112e8b9c1eadadd8cf5b13fda332c9d774eb7a0e96463fa3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2006</creationdate><topic>Anticholesteremic Agents - administration &amp; dosage</topic><topic>Atorvastatin Calcium</topic><topic>Coronary Artery Disease - complications</topic><topic>Coronary Artery Disease - drug therapy</topic><topic>Coronary Circulation - drug effects</topic><topic>Heptanoic Acids</topic><topic>Humans</topic><topic>Hypercholesterolemia - complications</topic><topic>Hypercholesterolemia - diagnostic imaging</topic><topic>Hypercholesterolemia - drug therapy</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Organophosphorus Compounds</topic><topic>Organotechnetium Compounds</topic><topic>Pyrroles</topic><topic>Radionuclide Imaging</topic><topic>Radiopharmaceuticals</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Feola, Mauro</creatorcontrib><creatorcontrib>Biggi, Alberto</creatorcontrib><creatorcontrib>Rolfo, Fabrizio</creatorcontrib><creatorcontrib>Papaleo, Alberto</creatorcontrib><creatorcontrib>Chauvie, Stephane</creatorcontrib><creatorcontrib>Scala, Eugenio La</creatorcontrib><creatorcontrib>Uslenghi, Eugenio</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Clinical nuclear medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Feola, Mauro</au><au>Biggi, Alberto</au><au>Rolfo, Fabrizio</au><au>Papaleo, Alberto</au><au>Chauvie, Stephane</au><au>Scala, Eugenio La</au><au>Uslenghi, Eugenio</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Atorvastatin Improves Myocardial Perfusion in a Patient With Hypercholesterolemia and Single-Vessel Coronary Disease</atitle><jtitle>Clinical nuclear medicine</jtitle><addtitle>Clin Nucl Med</addtitle><date>2006-03</date><risdate>2006</risdate><volume>31</volume><issue>3</issue><spage>166</spage><epage>167</epage><pages>166-167</pages><issn>0363-9762</issn><eissn>1536-0229</eissn><abstract>Lipid-lowering agents may improve the prognosis in patients with coronary artery disease (CAD) or with risk factors for atherosclerosis. A high dose of atorvastatin (80 mg/d) reduced the LDL cholesterol level in stable patients with CAD and was seen to be as effective as coronary angioplasty in reducing the incidence of ischemic events. In patients with acute coronary syndrome, high-dose atorvastatin (80 mg/d) has lowered the incidence of recurrent ischemic events and emergency rehospitalization. We demonstrated that long-term oral low-dose (10 mg/d) administration of atorvastatin improved myocardial uptake of Tc-99m tetrofosmin in a patient with single-vessel coronary artery disease normalizing the plasma level of LDL cholesterol. The normalization of the perfusion pattern was obtained using the same protocol and level of physical stress after 10 months of therapy.</abstract><cop>United States</cop><pub>Lippincott Williams &amp; Wilkins, Inc</pub><pmid>16495741</pmid><doi>10.1097/01.rlu.0000200731.36549.d7</doi><tpages>2</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0363-9762
ispartof Clinical nuclear medicine, 2006-03, Vol.31 (3), p.166-167
issn 0363-9762
1536-0229
language eng
recordid cdi_proquest_miscellaneous_67689224
source MEDLINE; Journals@Ovid Complete
subjects Anticholesteremic Agents - administration & dosage
Atorvastatin Calcium
Coronary Artery Disease - complications
Coronary Artery Disease - drug therapy
Coronary Circulation - drug effects
Heptanoic Acids
Humans
Hypercholesterolemia - complications
Hypercholesterolemia - diagnostic imaging
Hypercholesterolemia - drug therapy
Male
Middle Aged
Organophosphorus Compounds
Organotechnetium Compounds
Pyrroles
Radionuclide Imaging
Radiopharmaceuticals
Treatment Outcome
title Atorvastatin Improves Myocardial Perfusion in a Patient With Hypercholesterolemia and Single-Vessel Coronary Disease
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-16T16%3A08%3A29IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Atorvastatin%20Improves%20Myocardial%20Perfusion%20in%20a%20Patient%20With%20Hypercholesterolemia%20and%20Single-Vessel%20Coronary%20Disease&rft.jtitle=Clinical%20nuclear%20medicine&rft.au=Feola,%20Mauro&rft.date=2006-03&rft.volume=31&rft.issue=3&rft.spage=166&rft.epage=167&rft.pages=166-167&rft.issn=0363-9762&rft.eissn=1536-0229&rft_id=info:doi/10.1097/01.rlu.0000200731.36549.d7&rft_dat=%3Cproquest_cross%3E67689224%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=67689224&rft_id=info:pmid/16495741&rfr_iscdi=true